Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate plus phototherapy versus placebo plus phototherapy for vitiligo
IRCT20221013056158N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Vitiligo comparing Placebo + phototherapy with Methotrexate + phototherapy (2 arms). Primary endpoints: Vitiligo Area Scoring Index, Vitiligo Disease Activity and 1 more. Started Mar 2021; status: completed.
02
Drugs
methotrexate
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20221013056158N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221013056158N1.